Phantom limb pain (PLP) encapsulates the complex spectrum of pain, both physical and psychological. It serves as a reminder of how deeply interconnected our minds and bodies are and how the presence of pain can persist even in the absence of a physical cause. Understanding and treating PLP requires a holistic approach that considers the intricate interplay between the brain, body, and mind. This integrated perspective helps provide more comprehensive and effective relief for those experiencing this challenging condition.

Phantom limb pain (PLP) is a common complication after major lower extremity amputations (MLEA), occurring in approximately 85% of patients. PLP significantly affects amputees’ mobility, ability to perform tasks of daily living, and overall quality of life (QoL). Previous studies have discussed surgical treatments for PLP that can improve ambulation and mobility after MLEA. The authors describe 3 patients who underwent peripheral nerve repair PNR to alleviate PLP and reported decreased pain and improved QoL.

Despite a recent increase in research efforts regarding disparities in peripheral arterial disease/critical limb-threatening ischemia (PAD/CLTI), few studies have focused on minority and women participation in late-breaking clinical investigations exploring various treatments for PAD/CLTI. The authors seek to explore the representation of minority groups and women in clinical studies evaluating the usage of drug-coated balloons for treatment in PAD/CLTI.

Intravascular lithotripsy (IVL) has emerged as a vessel preparation device for heavily calcified arteries during endovascular therapies.⁸ IVL utilizes multiple emitters mounted on a traditional angioplasty balloon catheter to deliver pulsatile acoustic pressure energy. This approach facilitates the fracture of superficial and deep calcium without compromising local soft tissues and minimizes the risk of emboli liberation.⁹ In this manuscript, the authors provide a comprehensive review of the role of IVL as an adjunct to endovascular revascularization in the treatment of PAD.